SELECTBIO Conferences 2D-to-3D Culture and Organoids 2020
2D-to-3D Culture and Organoids 2020
Date: March 25 - 26, 2020
Venue: Wyndham Boston Beacon Hill, Boston, MA USA

Conference Chairs

Terry Riss

Terry Riss
Global Strategic Marketing Manager Cell Health, Promega Corporation

Roger Kamm

Roger Kamm
Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT)

Keynote Speakers

Linda Griffith

Linda Griffith
Professor, Massachusetts Institute of Technology (MIT)

Roger Kamm

Roger Kamm
Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT)

Donna Mendrick

Donna Mendrick
Associate Director of Regulatory Activities, US Food and Drug Administration (FDA)

Gary Gintant

Gary Gintant
Senior Research Fellow, Abbvie

Michael Shuler

Michael Shuler
Samuel B. Eckert Professor of Engineering, Cornell University, President & CEO, Hesperos, Inc.

Albert Folch

Albert Folch
Professor of Bioengineering, University of Washington

Peter Ertl

Peter Ertl
Professor of Lab-on-a-Chip Systems, Vienna University of Technology

Overview

Welcome to the SelectBIO 2D-to-3D Culture and Organoids 2020 Conference to be held March 25-26, 2020 in Boston.

This conference brings together the innovations in 3D-Culture and Organoids, circa 2020 and bring the key opinion leaders and thought leaders in the field from around the world for two intensive days of scientific presentations, networking as well as engagement with companies developing innovations in tools and technologies in this expanding space.

The meeting is held co-located and concurrently with the following additional track:
  • Multi-Cellular Engineered Living Systems Summit 2020
Attendees receive full access to all co-located tracks, all networking receptions and co-located exhibit hall.

Call for Posters

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!

Poster Submission Deadline: 29 February 2020

Agenda Topics

  • Case Studies using Organoids in Research, High Throughput Screening and Personalized Medicine
  • Converting from 2D to 3D Culture Models
  • Development and use of Advanced Microfluidic Chip Devices for Co-Culturing Organoids
  • Emerging Technologies for Reproducible Production of Organoids
  • High Content Imaging and Phenotypic Assays of 3D Culture Models
  • Tumor Organoids

Sponsorship and Exhibition Opportunities

For more details, please contact us.

Confirmed Speakers to date

Jeffrey Borenstein, Group Leader, Synthetic Biology, Draper
Yu-Chi Chen, Scientist, Bioprinting Group, NCATS
Erin Edwards, Head of Services, Visikol
Jeonghyun Kim, Researcher, Kyoto University
Milos Kostic, Scholar, Novartis Institutes for BioMedical Research
Ryuji Morizane, Assistant Professor, Harvard Medical School; Visiting Scholar, Wyss Institute
Rene Overmeer, Assay Development & Screening Manager, Hubrecht Organoid Technology (HUB)
Jennifer Rosenbluth, Instructor in Medicine, Dana-Farber Cancer Institute
Shay Soker, Professor of Regenerative Medicine, Wake Forest Institute for Regenerative Medicine
Matthias von Herrath, Vice President and Senior Medical Officer, Novo Nordisk, Professor, La Jolla Institute
Qin Wang, Scientist, Drug Safety Research & Evaluation, Takeda Pharmaceuticals, Inc.


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks
Corporate Sponsors
Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean


Update History
2020/02/05
Agenda,Speaker,Sponsor updated
2020/01/09
Event Information updated
2019/12/25
Event Information updated
2019/12/13
Speaker updated